4//SEC Filing
BALDO LANCE 4
Accession 0001209191-21-018745
CIK 0001478320other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:00 PM ET
Size
7.1 KB
Accession
0001209191-21-018745
Insider Transaction Report
Form 4
BALDO LANCE
Chief Medical Officer
Transactions
- Award
Common Stock
2021-03-04+22,894→ 22,894 total - Award
Stock Option (Right to Buy)
2021-03-04+57,234→ 57,234 totalExercise: $43.68Exp: 2021-03-04→ Common Stock (57,234 underlying)
Footnotes (1)
- [F1]The options vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780773
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 7:00 PM ET
- Size
- 7.1 KB